Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
Abstract Breast cancer (BC) has a high mortality rate and is one of the most common malignancies in the world. Initially, BC was considered non-immunogenic, but a paradigm shift occurred with the discovery of tumor-infiltrating lymphocytes (TILs) and regulatory T cells (Tregs) in the BC tumor microe...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-07-01
|
Series: | European Journal of Medical Research |
Online Access: | https://doi.org/10.1186/s40001-024-01901-9 |